Proactive Investors - Run By Investors For Investors

1933 Industries bolsters cannabis extraction capacity at Las Vegas facility

The company plans to expand its production area to 2,215 square feet from 483 square feet, doubling its distillate production capacity
Las Vegas cultivation facility
Once its cannabis plants are moved to a new cultivation facility, the company will submit layout plans to the city of Las Vegas for approval

1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF) is ramping up extraction of cannabis concentrates at its cultivation facility in Nevada.

The company plans to build improvements at the Alternative Medicine Association cultivation facility in Las Vegas to expand its production area to 2,215 square feet from 483 square feet, doubling its potential production capacity to 80 liters of distillate per month.

Once its cannabis plants are moved to a new cultivation facility, the company will submit layout plans to the city of Las Vegas for approval. The operation is expected to kick into gear in the fall of 2019.

READ: 1933 Industries gets permanent occupancy permit for Las Vegas cultivation facility

Additionally, the Vancouver-based company is working with an engineering firm on custom equipment to establish one of Nevada’s largest hemp-extraction facilities. The operation will be capable of isolating cannabidiol, cannabinol, cannabigerol, cannabichromene and several other cannabinoids to create oils and isolates.

The company has ordered its custom and is working on the final layout. Its processing capacity is expected to be roughly 68,000 kilograms of hemp biomass per month, which would yield about 5,000 kilograms of oils or 4,500 kilograms of CBD isolate.

"The process has been scaled up after a lengthy research phase, where we aimed to create a method of extraction using specialized chemistry and equipment in order to obtain a higher yield of CBD, thus increasing our efficiency,” CEO Chris Rebentisch said. “The competitive advantage of the new facility will be the isolation of not only CBD but of additional individual cannabinoids at scale, which is unique and novel in the cannabis marketplace."

The company's stock slid 2.4% on Friday to C$0.41 on the CSE and 2.6% to US$0.31 on OTC Markets. 

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TGIF profile View Profile

1933 Industries Timeline

Related Articles

medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
cannabis plan in sun
February 21 2019
The cannabis company will manufacture, infuse and package branded recreational and wellness products
cannabis
June 08 2019
1933 Industries is progressing with plans to launch one of Nevada's largest hemp extraction facilities, amid a flurry of other activity

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use